Redmile Group, LLC Kymera Therapeutics, Inc. Transaction History

Redmile Group, LLC

  • $1.53 Billion
  • Q3 2024

A detailed history of Redmile Group, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 1,393,256 shares of KYMR stock, worth $62.7 Million. This represents 4.31% of its overall portfolio holdings.

Number of Shares
1,393,256
Previous 1,579,275 11.78%
Holding current value
$62.7 Million
Previous $47.1 Million 39.88%
% of portfolio
4.31%
Previous 3.07%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$30.16 - $52.4 $5.61 Million - $9.75 Million
-186,019 Reduced 11.78%
1,393,256 $65.9 Million
Q2 2024

Aug 14, 2024
SELL
$29.85 - $39.42 $4.62 Million - $6.1 Million
-154,814 Reduced 8.93%
1,579,275 $47.1 Million
Q1 2024

May 15, 2024
SELL
$22.9 - $43.57 $2.06 Million - $3.92 Million
-89,867 Reduced 4.93%
1,734,089 $69.7 Million
Q4 2023

Feb 14, 2024
SELL
$10.97 - $26.84 $488,724 - $1.2 Million
-44,551 Reduced 2.38%
1,823,956 $46.4 Million
Q2 2023

Aug 14, 2023
SELL
$22.4 - $34.92 $12.1 Million - $18.9 Million
-542,262 Reduced 22.49%
1,868,507 $43 Million
Q1 2023

May 15, 2023
SELL
$24.84 - $38.75 $6.53 Million - $10.2 Million
-263,068 Reduced 9.84%
2,410,769 $71.4 Million
Q4 2022

Feb 14, 2023
SELL
$19.57 - $30.92 $3.97 Million - $6.27 Million
-202,800 Reduced 7.05%
2,673,837 $66.7 Million
Q3 2022

Nov 14, 2022
BUY
$20.91 - $34.27 $5.64 Million - $9.24 Million
269,507 Added 10.34%
2,876,637 $62.6 Million
Q2 2022

Aug 15, 2022
SELL
$14.13 - $42.55 $111,627 - $336,145
-7,900 Reduced 0.3%
2,607,130 $51.3 Million
Q1 2022

May 16, 2022
BUY
$35.3 - $64.68 $963,689 - $1.77 Million
27,300 Added 1.05%
2,615,030 $111 Million
Q4 2021

Feb 14, 2022
SELL
$49.91 - $65.56 $10.3 Million - $13.5 Million
-205,978 Reduced 7.37%
2,587,730 $164 Million
Q3 2021

Nov 15, 2021
BUY
$47.8 - $66.66 $12.5 Million - $17.5 Million
262,200 Added 10.36%
2,793,708 $164 Million
Q2 2021

Aug 16, 2021
SELL
$31.08 - $51.95 $2.23 Million - $3.72 Million
-71,631 Reduced 2.75%
2,531,508 $123 Million
Q1 2021

May 17, 2021
SELL
$35.64 - $85.46 $4.18 Million - $10 Million
-117,350 Reduced 4.31%
2,603,139 $101 Million
Q4 2020

Feb 16, 2021
SELL
$28.07 - $87.83 $341,639 - $1.07 Million
-12,171 Reduced 0.45%
2,720,489 $169 Million
Q3 2020

Nov 16, 2020
BUY
$26.1 - $33.28 $71.3 Million - $90.9 Million
2,732,660 New
2,732,660 $88.3 Million

Others Institutions Holding KYMR

# of Institutions
184
Shares Held
64.4M
Call Options Held
50.6K
Put Options Held
81.7K
View Full List

About Kymera Therapeutics, Inc.

KYMR Quotes by TradingView
  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.46B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email